Nexalin (NXL) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Nexalin Revenue Highlights


Latest Revenue (Y)

$110.75K

Latest Revenue (Q)

$26.84K

Main Segment (Y)

Licensing Fee

Main Geography (Y)

UNITED STATES

Nexalin Revenue by Period


Nexalin Revenue by Year

DateRevenueChange
2023-12-31$110.75K-91.62%
2022-12-31$1.32M817.20%
2021-12-31$144.06K-40.69%
2020-12-31$242.91K17.13%
2019-12-31$207.38K-

Nexalin generated $110.75K in revenue during NA 2023, up -91.62% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Nexalin Revenue by Quarter

DateRevenueChange
2024-06-30$26.84K-65.88%
2024-03-31$78.67K283.09%
2023-12-31$20.54K-14.83%
2023-09-30$24.11K-32.15%
2023-06-30$35.54K16.30%
2023-03-31$30.56K-20.47%
2022-12-31$38.42K-92.95%
2022-09-30$545.32K31.63%
2022-06-30$414.29K28.13%
2022-03-31$323.32K1247.23%
2021-12-31$24.00K-57.12%
2021-09-30$55.97K91.99%
2021-06-30$29.15K-16.57%
2021-03-31$34.94K7.51%
2020-12-31$32.50K-11.93%
2020-09-30$36.91K-57.46%
2020-06-30$86.75K-0.00%
2020-03-31$86.75K-

Nexalin generated $26.84K in revenue during Q2 2024, up -65.88% compared to the previous quarter, and up 87.83% compared to the same period a year ago.

Nexalin Revenue Breakdown


Nexalin Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Other$1.37K$26.41K
Equipment$27.30K$26.78K
Licensing Fee$82.08K$79.19K
Device Sales-$1.16M

Nexalin's latest annual revenue breakdown by segment (product or service), as of Dec 23: Licensing Fee (74.11%), Equipment (24.65%), and Other (1.24%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
Licensing Fee$21.56K$19.51K$18.66K$20.03K$23.87K$18.63K$21.11K
Equipment$1.51K$10.62K$5.18K$5.10K$6.40K$4.75K$4.10K
Other$100.00$2.00$270.00$807.00$290.00$275.00$110.00
Device Sales$55.50K$9.60K-$520.00K---

Nexalin's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Device Sales (70.55%), Licensing Fee (27.40%), Equipment (1.92%), and Other (0.13%).

Nexalin Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
UNITED STATES$107.13K$113.54K
CHINA$3.61K$1.21M

Nexalin's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (96.74%), and CHINA (3.26%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22
UNITED STATES$23.17K$27.13K$24.11K$25.33K$30.56K$23.68K$25.32K
CHINA--$10.21K$14.75K$520.00K--

Nexalin's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (100.00%).

Nexalin Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
LIVNLivaNova$1.15B$318.11M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$132.58M$30.34M
NPCENeuroPace$65.42M$18.12M
IRIXIRIDEX$51.87M$12.63M
AZYOElutia$49.19M$6.13M
LNSRLENSAR$42.16M$10.59M
SSKNSTRATA Skin Sciences$33.36M$8.44M
OSAProSomnus$27.65M$7.46M
INVOINVO Bioscience$3.02M$1.58M
MOTSMotus GI$319.00K$64.00K
AIMDAinos$122.11K-
NXLNexalin$110.75K$26.84K
BJDXBluejay Diagnostics--
MODDModular Medical--

NXL Revenue FAQ


Nexalin's yearly revenue for 2023 was $110.75K, representing a decrease of -91.62% compared to 2022. The company's yearly revenue for 2022 was $1.32M, representing an increase of 817.20% compared to 2021. NXL's yearly revenue for 2021 was $144.06K, representing a decrease of -40.69% compared to 2020.

Nexalin's quarterly revenue for Q2 2024 was $26.84K, a -65.88% decrease from the previous quarter (Q1 2024), and a -24.48% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $78.67K, a 283.09% increase from the previous quarter (Q4 2023), and a 157.43% increase year-over-year (Q1 2023). NXL's quarterly revenue for Q4 2023 was $20.54K, a -14.83% decrease from the previous quarter (Q3 2023), and a -46.55% decrease year-over-year (Q4 2022).

Nexalin's revenue growth rate for the last 3 years (2021-2023) was -23.13%, and for the last 5 years (2019-2023) was -46.60%.

Nexalin's revenue streams in c 23 are Other, Equipment, and Licensing Fee. Other generated $1.37K in revenue, accounting 1.24% of the company's total revenue, down -94.82% year-over-year. Equipment generated $27.3K in revenue, accounting 24.65% of the company's total revenue, up 1.95% year-over-year. Licensing Fee generated $82.08K in revenue, accounting 74.11% of the company's total revenue, up 3.65% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Nexalin was Licensing Fee. This segment made a revenue of $82.08K, representing 74.11% of the company's total revenue.